p16 expression in colorectal adenocarcinoma: marker of aggressiveness and morphological types

References

• Parkin D M, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005; 55: 74–108
   PubMed Web of Science ®Google Scholar
• Sung J J, Lau J Y, Goh K L, Leung W. Asia Pacific Working Group on Colorectal Cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 2005; 6: 871–876
   PubMed Web of Science ®Google Scholar
• Lam A K, Ong K, Ho Y H. Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 Expression. Dis Colon Rectum 2006; 49: 1275–1283
   PubMed Web of Science ®Google Scholar
• Lam A K, Ho Y H. Primary squamous cell carcinoma of the rectum in a patient on immunosuppressive therapy. Pathology 2006; 38: 74–76
   PubMed Web of Science ®Google Scholar
• Alvarado M D, Jensen E H, Yeatman T J. The potential role of gene expression in the management of primary and metastatic colorectal cancer. Cancer Control 2006; 13: 27–31
   PubMedGoogle Scholar
• Kim W Y, Sharpless N E. The regulation of INK4/ARF in cancer and aging. Cell 2006; 127: 265–275
   PubMed Web of Science ®Google Scholar
• Yuen P W, Man M, Lam K Y, Kwong Y L. Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. J Clin Pathol 2002; 55: 58–60
   PubMed Web of Science ®Google Scholar
• Lam A K, Lo C Y, Leung P, Lang B H, Chan W F, Luk J M. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma. Ann Surg Oncol 2007; 14: 1772–1779
   PubMed Web of Science ®Google Scholar
• McCluggage W G. Immunohistochemistry as a diagnostic aid in cervical pathology. Pathology 2007; 39: 97–111
   PubMed Web of Science ®Google Scholar
• Palmqvist R, Rutegard J N, Bozoky B, Landberg G, Stenling R. Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters. Am J Pathol 2000; 157: 1947–1953
   PubMed Web of Science ®Google Scholar
• McKay J A, Douglas J J, Ross V G, et al. Analysis of key cell-cycle checkpoint proteins in colorectal tumours. J Pathol 2002; 196: 386–393
   PubMed Web of Science ®Google Scholar
• Norrie M W, Hawkins N J, Todd A V, Meagher A P, O'Connor T W, Ward R L. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer. J Surg Oncol 2003; 84: 143–150
   PubMed Web of Science ®Google Scholar
• Schneider-Stock R, Boltze C, Peters B, et al. Differences in loss of p16INK4 protein expression by promoter methylation between left- and right-sided primary colorectal carcinomas. Int J Oncol 2003; 23: 1009–1013
   PubMed Web of Science ®Google Scholar
• Tada T, Watanabe T, Kazama S, et al. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers. Hepatogastroenterology 2003; 50: 1756–1760
   PubMed Web of Science ®Google Scholar
• Cui X, Shirai Y, Wakai T, Yokoyama N, Hirano S, Hatakeyama K. Aberrant expression of pRb and p16(INK4), alone or in combination, indicates poor outcome after resection in patients with colorectal carcinoma. Hum Pathol 2004; 35: 1189–1195
   PubMed Web of Science ®Google Scholar
• Carneiro F P, Ramalho L N, Britto-Garcia S, Ribeiro-Silva A, Zucoloto S. Immunohistochemical expression of p16, p53, and p63 in colorectal adenomas and adenocarcinomas. Dis Colon Rectum 2006; 49: 588–594
   PubMed Web of Science ®Google Scholar
• Zhao P, Mao X, Talbot I C. Aberrant cytological localization of p16 and CDK4 in colorectal epithelia in the normal adenoma carcinoma sequence. World J Gastroenterol 2006; 12: 6391–6396
   PubMed Web of Science ®Google Scholar
• Zhao P, Hu Y C, Talbot I C. Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma. World J Gastroenterol 2003; 9: 2202–2206
   PubMed Web of Science ®Google Scholar
• Hamilton S R, Vogelstein B, Kudo S, . Carcinoma of the colon and rectum. WHO Classification of Tumours: Pathology and Genetics of Tumours of Digestive System, S R Hamilton, L A Aaltonen, et al. IARC Press, Lyon 2000; 105–119
   Google Scholar
• Greene F L, Page D L, Fleming I D, et al. AJCC Cancer Staging Manual. 6^th ed. Springer-Verlag, Berlin 2002
   Google Scholar
• Iacopetta B. Are there two sides to colorectal cancer?. Int J Cancer 2002; 101: 403–408
   PubMed Web of Science ®Google Scholar
• Kapiteijn E, Liefers G J, Los L C, et al. Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol 2001; 195: 171–178
   PubMed Web of Science ®Google Scholar
• Birkenkamp-Demtroder K, Olesen S H, Sorensen F B, et al. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 2005; 54: 374–384
   PubMed Web of Science ®Google Scholar
• Lam K Y, Law S, Lo T, Tung H M, Wong J. The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients. Am J Gastroenterol 1999; 94: 2060–2068
   PubMed Web of Science ®Google Scholar
• Lam K Y, Chan A CL, Chan K W, Leung M L, Srivastava G. Expression of p53 and its relationship with human papillomavirus in penile carcinomas. Eur J Surg Oncol 1995; 21: 613–616
   PubMedGoogle Scholar
• Lam K Y, Lo C Y, Chan K W, Wan K Y. Insular and anaplastic carcinoma of the thyroid: A 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg 2000; 231: 329–338
   PubMed Web of Science ®Google Scholar